No Data
No Data
[Brokerage Focus] Guolian Securities maintains a "buy" rating on H&H International Holdings (01112), but the impact of the baby and child business still exists.
Guolian Securities issued a research report, stating that H&H International Holdings (01112) achieved revenue of 6.692 billion yuan in the first half of the year, a year-on-year decrease of -4.1%; the adjusted net income was 0.347 billion yuan, a year-on-year decrease of -32.4%. The bank pointed out that the adult health business (Swisse) achieved revenue of 3.276 billion yuan in 2024H1, a year-on-year increase of +11.5% despite the high base; due to the impact of birth rate and the switch of new and old national standard products, the infant formula business in 2024H1 decreased by -18.8% year-on-year (the overall infant and child business decreased by -22.0% year-on-year). Although there is still short-term pressure, the decrease in Q2 is significantly smaller compared to the previous quarter.
H&H International Halves Profit in H1
Express News | Health and Happiness (H&H) International - Hy Net Profit RMB 305.8 Mln
Express News | Health and Happiness (H&H) International - Interim Dividend of HKD0.30 per Share
Interim Results Announcement for the Six Months Ended 30 June 2024
H&H International Holdings (01112.HK) held a board of directors meeting on August 27 to consider and approve mid-term performance.
H&H International Holdings (01112.HK) announced that it will hold a board of directors meeting at 9:00 am on Tuesday, August 27, 2024 (tentatively) at units 4007-09, 40/F, One Island East, 18 Westlands Road, Quarry Bay, Hong Kong to consider and approve the Group's interim results for the six months ended June 30, 2024, the payment of interim dividends (if any), and deal with other matters.
No Data